NUSINERSEN

Brand name:

• Spinraza®

Pharmaceutical company:

Biogen Australia Pty Ltd

Condition/indication:
(therapeutic use)

• Spinal muscular atrophy

PBAC Submission type:

New listing (Minor)

Comment:

Submission received deferred outcome at the July 2019 PBAC meeting.

Public Summary Document:

PBAC Public Summary Documents - November 2019

Related medicines:

• NUSINERSEN

Submission received for:

Not applicable

Opportunity for consumer comment:

Not applicable

PBAC meeting:

Held on 06/11/2019

PBAC outcome published:

Not Recommended (see PBAC Outcomes)

Lodgement of required documentation:

Not applicable

Agreement to listing arrangements:

Not applicable

Government processes:

Not applicable

Medicine listed on the PBS:

Not applicable

---